Pfizer to Acquire Biohaven Pharmaceuticals for $11.7 Billion May 16, 2022 Auto Bot News 0 Pfizer will acquire Biohaven Pharmaceuticals, a clinical-stage biopharmaceutical company specializing in migraine treatments, for $11.7 billion.
